Parasite-driven pathogenesis in Trypanosoma brucei infections

Parasite Immunology

Volumn 33, Issue 8, 2011, Pages 448-455

  Morrison, L J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Innate immunity; Nagana; Pathogenesis; Sleeping sickness; Trypanosome

Indexed keywords

VIRULENCE FACTOR;

AFRICAN TRYPANOSOMIASIS; DISEASE COURSE; DISEASE SEVERITY; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; NONHUMAN; PARASITE; PARASITE VIRULENCE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRYPANOSOMA BRUCEI;

ANIMALS; GENE EXPRESSION; GENES, PROTOZOAN; GENETIC VARIATION; GENOTYPE; HOST-PARASITE INTERACTIONS; HUMANS; MACROPHAGE ACTIVATION; MICE; PHENOTYPE; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; VIRULENCE;

MAMMALIA; PROTOZOA; TRYPANOSOMA BRUCEI;

EID: 79960409787     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2011.01286.x     Document Type: Review

References (76)

1. Barrett MP, Burchmore RJ, Stich A, et al. The trypanosomiases. Lancet 2003; 362: 1469-1480.
2. Naessens J. Bovine trypanotolerance: a natural ability to prevent severe anaemia and haemophagocytic syndrome? Int J Parasitol 2006; 36: 521-528.
3. Hanotte O, Ronin Y, Agaba M, et al. Mapping of quantitative trait loci controlling trypanotolerance in a cross of tolerant West African N'Dama and susceptible East African Boran cattle. Proc Natl Acad Sci U S A 2003; 100: 7443-7448.
4. Kemp SJ, Iraqi F, Darvasi A, Soller M & Teale AJ. Localization of genes controlling resistance to trypanosomiasis in mice. Nat Genet 1997; 16: 194-196.
5. Hoare CA. The Trypanosomes of Mammals. A Zoological Monograph. Oxford, UK, Blackwell Scientific Publications, 1972.
6. Garcia A, Courtin D, Solano P, Koffi M & Jamonneau V. Human African trypanosomiasis: connecting parasite and host genetics. Trends Parasitol 2006; 22: 405-409.
7. Sternberg JM & MacLean L. A spectrum of disease in Human African trypanosomiasis: the host and parasite genetics of virulence. Parasitology 2010; 137: 2007-2015.
8. Stijlemans B, Guilliams M, Raes G, Beschin A, Magez S & De Baetselier P. African trypanosomosis: from immune escape and immunopathology to immune intervention. Vet Parasitol 2007; 148: 3-13.
9. Mansfield JM & Paulnock DM. Regulation of innate and acquired immunity in African trypanosomiasis. Parasite Immunol 2005; 27: 361-371.
10. Magez S, Truyens C, Merimi M, et al. P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J Infect Dis 2004; 189: 527-539.
11. Holzmuller P, Biron DG, Courtois P, et al. Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics. Microbes Infect 2008; 10: 79-86.
12. Turner CM. The use of experimental artefacts in African trypanosome research. Parasitol Today 1990; 6: 14-17.
13. Vassella E, Reuner B, Yutzy B & Boshart M Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. J Cell Sci 1997; 110 (Pt 21): 2661-2671.
14. Reuner B, Vassella E, Yutzy B & Boshart M. Cell density triggers slender to stumpy differentiation of Trypanosoma brucei bloodstream forms in culture. Mol Biochem Parasitol 1997; 90: 269-280.
15. Morrison LJ, McLellan S, Sweeney L, et al. Role for parasite genetic diversity in differential host responses to Trypanosoma brucei infection. Infect Immun 2010; 78: 1096-1108.
16. Foote SJ, Iraqi F & Kemp SJ. Controlling malaria and African trypanosomiasis: the role of the mouse. Brief Funct Genomic Proteomic 2005; 4: 214-224.
17. Antoine-Moussiaux N, Magez S & Desmecht D. Contributions of experimental mouse models to the understanding of African trypanosomiasis. Trends Parasitol 2008; 24: 411-418.
18. Grech K, Watt K & Read AF. Host-parasite interactions for virulence and resistance in a malaria model system. J Evol Biol 2006; 19: 1620-1630.
19. Mackinnon MJ & Read AF. Virulence in malaria: an evolutionary viewpoint. Philos Trans R Soc Lond B Biol Sci 2004; 359: 965-986.
20. Mackinnon MJ, Gaffney DJ & Read AF. Virulence in rodent malaria: host genotype by parasite genotype interactions. Infect Genet Evol 2002; 1: 287-296.
21. Mackinnon MJ & Marsh K. The selection landscape of malaria parasites. Science 2010; 328: 866-871.
22. Peacock CS, Seeger K, Harris D, et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 2007; 39: 839-847.
23. Zhang WW, Peacock CS & Matlashewski G. A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania. PLoS Negl Trop Dis 2008; 2: e248.
24. Saeij JP, Boyle JP, Coller S, et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 2006; 314: 1780-1783.
25. Taylor S, Barragan A, Su C, et al. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 2006; 314: 1776-1780.
26. Khan A, Taylor S, Ajioka JW, Rosenthal BM & Sibley LD. Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice. PLoS Genet 2009; 5: e1000404.
27. Duffy CW, Morrison LJ, Black A, et al. Trypanosoma vivax displays a clonal population structure. Int J Parasitol 2009; 39: 1475-1483.
28. Morrison LJ, Tweedie A, Black A, et al. Discovery of mating in the major African livestock pathogen Trypanosoma congolense. PLoS ONE 2009; 4: e5564.
29. MacLeod A, Tait A & Turner CM. The population genetics of Trypanosoma brucei and the origin of human infectivity. Philos Trans R Soc Lond B Biol Sci 2001; 356: 1035-1044.
30. MacLeod A, Tweedie A, Welburn SC, Maudlin I, Turner CM & Tait A. Minisatellite marker analysis of Trypanosoma brucei: reconciliation of clonal, panmictic, and epidemic population genetic structures. Proc Natl Acad Sci U S A 2000; 97: 13442-13447.
31. Morrison LJ, Tait A, McCormack G, et al. Trypanosoma brucei gambiense Type 1 populations from human patients are clonal and display geographical genetic differentiation. Infect Genet Evol 2008; 8: 847-854.
32. Koffi M, De MeeusT, Bucheton B, et al. Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa. Proc Natl Acad Sci U S A 2009; 106: 209-214.
33. Beckers A, Wery M, Van Marck E & Gigase P. Experimental infections of laboratory rodents with recently isolated stocks of Trypanosoma brucei gambiense. 1. Parasitological investigations. Z Parasitenkd 1981; 64: 285-296.
34. Van MarckEA, Gigase PL, Beckers A & Wery M. Experimental infections of laboratory rodents with recently isolated stocks of Trypanosoma brucei gambiense. 2. Histopathological investigations. Z Parasitenkd 1981; 64: 187-193.
35. Grab DJ, Nikolskaia O, Kim YV, et al. African trypanosome interactions with an in vitro model of the human blood-brain barrier. J Parasitol 2004; 90: 970-979.
36. Abdulla MH, O'Brien T, Mackey ZB, Sajid M, Grab DJ & McKerrow JH. RNA Interference of Trypanosoma brucei Cathepsin B and L Affects Disease Progression in a Mouse Model. PLoS Negl Trop Dis 2008; 2: e298.
37. Nikolskaia OV, de A. Lima APC, Kim YV, et al. Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease. J Clin Invest 2006; 116: 2739-2747.
38. Grab DJ, Garcia-Garcia JC, Nikolskaia OV, et al. Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells. PLoS Negl Trop Dis 2009; 3: e479.
39. Authie E, Boulange A, Muteti D, Lalmanach G, Gauthier F & Musoke AJ. Immunisation of cattle with cysteine proteinases of Trypanosoma congolense: targetting the disease rather than the parasite. Int J Parasitol 2001; 31: 1429-1433.
40. MacLeod A, Tweedie A, McLellan S, et al. The genetic map and comparative analysis with the physical map of Trypanosoma brucei. Nucleic Acids Res 2005; 33: 6688-6693.
41. Turner CM, Sternberg J, Buchanan N, Smith E, Hide G & Tait A. Evidence that the mechanism of gene exchange in Trypanosoma brucei involves meiosis and syngamy. Parasitology 1990; 101 (Pt 3): 377-386.
42. MacLeod A, Tweedie A, McLellan S, et al. Allelic segregation and independent assortment in T. brucei crosses: proof that the genetic system is Mendelian and involves meiosis. Mol Biochem Parasitol 2005; 143: 12-19.
43. Morrison LJ, Tait A, McLellan S, Sweeney L, Turner CM & MacLeod A. A major genetic locus in Trypanosoma brucei is a determinant of host pathology. PLoS Negl Trop Dis 2009; 3: e557.
44. MacLean L, Chisi JE, Odiit M, et al. Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile. Infect Immun 2004; 72: 7040-7044.
45. MacLean L, Odiit M, MacLeod A, et al. Spatially and genetically distinct African trypanosome virulence variants defined by host interferon-gamma response. J Infect Dis 2007; 196: 1620-1628.
46. Hertz CJ, Filutowicz H & Mansfield JM. Resistance to the African trypanosomes is IFN-gamma dependent. J Immunol 1998; 161: 6775-6783.
47. Namangala B, Noel W, De Baetselier P, Brys L & Beschin A. Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. J Infect Dis 2001; 183: 1794-1800.
48. Baetselier PD, Namangala B, Noel W, Brys L, Pays E & Beschin A. Alternative versus classical macrophage activation during experimental African trypanosomosis. Int J Parasitol 2001; 31: 575-587.
49. Namangala B, De Baetselier P, Noel W, Brys L & Beschin A. Alternative versus classical macrophage activation during experimental African trypanosomosis. J Leukoc Biol 2001; 69: 387-396.
50. Guilliams M, Oldenhove G, Noel W, et al. African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation. J Immunol 2007; 179: 2748-2757.
51. Wei G & Tabel H. Regulatory T cells prevent control of experimental African trypanosomiasis. J Immunol 2008; 180: 2514-2521.
52. Tabel H, Wei G & Shi M. T cells and immunopathogenesis of experimental African trypanosomiasis. Immunol Rev 2008; 225: 128-139.
53. Noyes HA, Alimohammadian MH, Agaba M, et al. Mechanisms controlling anaemia in Trypanosoma congolense infected mice. PLoS ONE 2009; 4: e5170.
54. Kierstein S, Noyes H, Naessens J, et al. Gene expression profiling in a mouse model for African trypanosomiasis. Genes Immun 2006; 7: 667-679.
55. Antoine-Moussiaux N, Buscher P & Desmecht D. Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy. Infect Immun 2009; 77: 1276-1284.
56. Morty RE, Lonsdale-Eccles JD, Mentele R, Auerswald EA & Coetzer TH. Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity. Infect Immun 2001; 69: 2757-2761.
57. Morty RE, Pelle R, Vadasz I, Uzcanga GL, Seeger W & Bubis J. Oligopeptidase B from Trypanosoma evansi. A parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts. J Biol Chem 2005; 280: 10925-10937.
58. Morrison LJ, Marcello L & McCulloch R. Antigenic variation in the African trypanosome: molecular mechanisms and phenotypic complexity. Cell Microbiol 2009; 11: 1724-1734.
59. Barry JD & McCulloch R. Antigenic variation in trypanosomes: enhanced phenotypic variation in a eukaryotic parasite. Adv Parasitol 2001; 49: 1-70.
60. Paulnock DM, Freeman BE & Mansfield JM. Modulation of innate immunity by African Trypanosomes. Parasitology 2010; 137: 2051-2063.
61. Magez S, Stijlemans B, Radwanska M, Pays E, Ferguson MA & De Baetselier P. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J Immunol 1998; 160: 1949-1956.
62. Leppert BJ, Mansfield JM & Paulnock DM. The soluble variant surface glycoprotein of African trypanosomes is recognized by a macrophage scavenger receptor and induces I kappa B alpha degradation independently of TRAF6-mediated TLR signaling. J Immunol 2007; 179: 548-556.
63. Magez S, Stijlemans B, Baral T & De Baetselier P. VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology. Microbes Infect 2002; 4: 999-1006.
64. Gomez-Rodriguez J, Stijlemans B, De Muylder G, et al. Identification of a parasitic immunomodulatory protein triggering the development of suppressive M1 macrophages during African trypanosomiasis. J Infect Dis 2009; 200: 1849-1860.
65. Urquhart GM, Murray M, Murray PK, Jennings FW & Bate E. Immunosuppression in Trypanosoma brucei infections in rats and mice. Trans R Soc Trop Med Hyg 1973; 67: 528-535.
66. Radwanska M, Guirnalda P, De Trez C, Ryffel B, Black S & Magez S. Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses. PLoS Pathog 2008; 4: e1000078.
67. Van den Bossche P, de La Rocque S, Hendrickx G & Bouyer J. A changing environment and the epidemiology of tsetse-transmitted livestock trypanosomiasis. Trends Parasitol 2010; 26: 236-243.
68. de Roode JC, Yates AJ & Altizer S. Virulence-transmission trade-offs and population divergence in virulence in a naturally occurring butterfly parasite. Proc Natl Acad Sci U S A 2008; 105: 7489-7494.
69. de Roode JC & Altizer S. Host-parasite genetic interactions and virulence-transmission relationships in natural populations of monarch butterflies. Evolution 2010; 64: 502-514.
70. McKeever DJ. Bovine immunity - a driver for diversity in Theileria parasites? Trends Parasitol 2009; 25: 269-276.
71. Mackinnon MJ, Bell A & Read AF. The effects of mosquito transmission and population bottlenecking on virulence, multiplication rate and rosetting in rodent malaria. Int J Parasitol 2005; 35: 145-153.
72. Oberle M, Balmer O, Brun R & Roditi I. Bottlenecks and the maintenance of minor genotypes during the life cycle of Trypanosoma brucei. PLoS Pathog 2010; 6: e1001023.
73. Telfer S, Lambin X, Birtles R, et al. Species interactions in a parasite community drive infection risk in a wildlife population. Science 2010; 330: 243-246.
74. Balmer O, Stearns SC, Schotzau A & Brun R. Intraspecific competition between co-infecting parasite strains enhances host survival in African trypanosomes. Ecology 2009; 90: 3367-3378.
75. Rodrigues CM, Valadares HM, Francisco AF, et al. Coinfection with different Trypanosoma cruzi strains interferes with the host immune response to infection. PLoS Negl Trop Dis 2010; 4: e846.
76. Garside P & Brewer JM. Real-time imaging of the cellular interactions underlying tolerance, priming, and responses to infection. Immunol Rev 2008; 221: 130-146.